Results 61 to 70 of about 38,863 (158)

Antiplatelet combinations for prevention of atherothrombotic events

open access: yes, 2011
Mario Bollat,i Fiorenzo Gaita, Matteo AnselminoDepartment of Internal Medicine, Division of Cardiology, University of Torino, ItalyAbstract: Antiplatelet therapy plays a fundamental role in reducing atherothrombotic events by several pathways.
Anselmino M, Bollati M, Gaita F
core  

Newer agents in antiplatelet therapy: a review

open access: yes, 2012
Jennifer Yeung, Michael HolinstatCardeza Foundation for Hematologic Research, Department of Medicine, Thomas Jefferson University, Philadelphia, PA, USAAbstract: Antiplatelet therapy remains the mainstay in preventing aberrant platelet activation in ...
Yeung J, Holinstat M
core  

Antiplatelet drug distribution.

open access: yes, 2016
Antiplatelet drug distribution.
Shaul Atar (2838758)   +11 more
core   +1 more source

To clot, or not to clot – Antithrombotic therapy is the question

open access: yesSouth African Family Practice, 2019
Haemostasis and thrombosis rely on three components namely the vascular endothelial wall, blood platelets and the coagulation cascade. Non-physiologic excessive thrombosis occurs when haemostatic processes are dysfunctional, causing undue clot formation ...
E. Osuch, A. Marais
doaj   +1 more source

Antiplatelet Therapy for Acute Respiratory Distress Syndrome

open access: yesBiomedicines, 2020
Acute respiratory distress syndrome (ARDS) is a common and devastating syndrome that contributes to serious morbidities and mortality in critically ill patients.
Chuan-Mu Chen   +3 more
doaj   +1 more source

Selection of medication in hospitalised elderly patients with Angina Pectoris [PDF]

open access: yes, 2004
Objective: To evaluate medication changes in hospitalised elderly patients diagnosed with angina pectoris and to compare the selection of medication with evidence-based treatment guidelines. Design: Review of medical notes and patient interview. Setting:
Gauci, Marise   +2 more
core  

Antiplatelet/anticoagulant agents and chronic subdural hematoma in the elderly [PDF]

open access: yes, 2013
In the last decade there has been an increasing use of antiplatelet/anticoagulant agents in the elderly. The aim of the study was to evaluate the association between exposure to anticoagulant/antiplatelet therapy and chronic subdural haematoma ...
Pompucci, Angelo   +23 more
core   +1 more source

Subgroup based on single antiplatelet therapy (SAPT) choice following dual antiplatelet therapy (DAPT) in the short DAPT arm.

open access: yes, 2023
Subgroup based on single antiplatelet therapy (SAPT) choice following dual antiplatelet therapy (DAPT) in the short DAPT arm.
Kevin R. Bainey (11060747)   +5 more
core   +1 more source

Atractylodes lactone compounds inhibit platelet activation

open access: yesPlatelets, 2017
Platelets play a crucial role in the development and progression of atherosclerosis-thrombosis and, therefore, antiplatelet drugs are widely used in the treatment of coronary artery disease. Moreover, advances in understanding the biological functions of
Yizhu Chen   +6 more
doaj   +1 more source

Subpopulation not taking antiplatelet.

open access: yes, 2014
Subpopulation not taking antiplatelet.
Matthew Ventresca (521869)   +9 more
core   +1 more source

Home - About - Disclaimer - Privacy